277 related articles for article (PubMed ID: 1260078)
1. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
Abrams R; Essman WB; Taylor MA; Fink M
Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
[TBL] [Abstract][Full Text] [Related]
2. Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients.
Jori A; Dolfini E; Casati C; Argenta G
Psychopharmacologia; 1975 Oct; 44(1):87-90. PubMed ID: 1105628
[TBL] [Abstract][Full Text] [Related]
3. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
[TBL] [Abstract][Full Text] [Related]
4. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
Kirstein L; Bowers MB; Heninger G
Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
[TBL] [Abstract][Full Text] [Related]
5. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
Banki CM; Molnar G
Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
[TBL] [Abstract][Full Text] [Related]
6. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
Sourkes TL; Young SN; Garelis E; Lal S
Acta Vitaminol Enzymol; 1975; 29(1-6):97-9. PubMed ID: 1244132
[TBL] [Abstract][Full Text] [Related]
7. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
[TBL] [Abstract][Full Text] [Related]
10. Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression.
Banki CM; Molnar G; Fekete I
Arch Psychiatr Nervenkr (1970); 1981; 229(4):345-53. PubMed ID: 6164353
[TBL] [Abstract][Full Text] [Related]
11. Effect of peripheral decarboxylase inhibition on HVA and 5HIAA in cerebrospinal fluid of depressed patients.
Gaillard JM; Constantinidis J; Tissot R
Neuropsychobiology; 1975; 1(1):26-31. PubMed ID: 1223666
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid amine metabolites in delirium tremens.
Banki CM; Molnar G
Psychiatr Clin (Basel); 1981; 14(3):167-77. PubMed ID: 6173895
[TBL] [Abstract][Full Text] [Related]
13. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow.
Young SN; Lal S; Martin JB; Ford RM; Sourkes TL
Psychiatr Neurol Neurochir; 1973; 76(6):439-44. PubMed ID: 4781523
[No Abstract] [Full Text] [Related]
14. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
[TBL] [Abstract][Full Text] [Related]
15. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the lumbar cerebrospinal fluid in epileptic patients].
Livrea P; Di Reda L; Puca FM; Genco S; Specchio L; Papagno G
Boll Soc Ital Biol Sper; 1976 Jun; 52(11):800-5. PubMed ID: 1016632
[No Abstract] [Full Text] [Related]
16. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms.
Banki CM; Molnar G; Vojnik M
J Affect Disord; 1981 Jun; 3(2):91-9. PubMed ID: 6166645
[TBL] [Abstract][Full Text] [Related]
17. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
Yamamoto M; Otsuki S; Miyake K; Namba R
No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
[No Abstract] [Full Text] [Related]
18. Bovine spastic paralysis: cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in normal and spastic calves.
De Ley G; De Moor A
Am J Vet Res; 1975 Feb; 36(2):227-8. PubMed ID: 1111389
[TBL] [Abstract][Full Text] [Related]
19. [Total sleep deprivation in normal humans. Changes in anxiety, depression and aggressiveness and HVA and 5-HIAA levels in the lumbar cerebrospinal fluid].
Genco S; Puca FM; Livrea P; Specchio LM; Lamberti P; Di Reda L; Papagno G
Boll Soc Ital Biol Sper; 1976 Jun; 52(11):794-9. PubMed ID: 1016631
[No Abstract] [Full Text] [Related]
20. Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
Schilkrut R; Rüther E; Ackenheil M; Eben E; Hippius H
Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):37-42. PubMed ID: 981321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
